Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Pepto-Bismol 17.5mg/1ml oral suspension (Procter & Gamble (Health & Beauty Care) Ltd) |
| BNF code | 010102100BBAWAG |
| Virtual Medicinal Product | Bismuth subsalicylate 17.5mg/1ml oral suspension sugar free |
| Name | Pepto-Bismol 17.5mg/1ml oral suspension |
| Date of name applicability | 18 Aug 2011 |
| Previous name | Pepto-Bismol 87.5mg/5ml oral suspension |
| Supplier | Procter & Gamble (Health & Beauty Care) Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Oral |
| Actual Medicinal Product Packs | |
| Pepto-Bismol 17.5mg/1ml oral suspension (Procter & Gamble (Health & Beauty Care) Ltd) 120 ml | |
| Pepto-Bismol 17.5mg/1ml oral suspension (Procter & Gamble (Health & Beauty Care) Ltd) 240 ml | |
| Pepto-Bismol 17.5mg/1ml oral suspension (Procter & Gamble (Health & Beauty Care) Ltd) 480 ml | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.